Krystal Biotech, Inc. (KRYS)
291.60
-14.69
(-4.80%)
USD |
NASDAQ |
May 18, 16:00
295.00
+3.40
(+1.17%)
After-Hours: 20:00
Krystal Biotech Research and Development Expense (Quarterly) : 13.81M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Scholar Rock Holding Corp. | 51.48M |
| TG Therapeutics, Inc. | 48.40M |
| Stoke Therapeutics, Inc. | 39.23M |
| Moderna, Inc. | 590.00M |
| Marker Therapeutics, Inc. | 2.843M |